Baiju Aurora

Market Access Transformation (MAT) revolutionizes the way advice is exchanged between healthcare stakeholders including Payers, manufacturers and the investment community. Our direct communication channel enables development of the most efficient clinical and commercial strategy. First round funding is secured and will be launching our first product in Q2 2016.

Providing strategic advisory support to Pharma/Biotech companies and consultancies in the areas of HEOR and P&MA.

Responsible for generating overall revenue (Business Development and Marketing) of existing Pricing and Market Access Service Offerings by expanding the client base in the US, Europe, and Asia while establishing MKTXS as a HEOR center of excellence, and recruiting, training, and motivating Sales and Project Delivery staff to meet the needs of new clients globally.

(Previously, Director/Senior Director/VP) Responsible for leading a Global Business Development team working with a client base in the US, EU5, and Nordics to fulfill the needs of small to large pharmaceutical / biotech / medical device companies in the areas of Health Economics and Outcomes Research, Value/Cost-Based Pricing, Market Assessment and Market Access Solutions.

Launched a start-up biotech company and its first in class injectable drug, Macugen, to Retina Specialists. Communicated Medicare/Third Party Reimbursement and secured Formulary approvals